SHL:ASXSonic Healthcare Limited Analysis

Technical outlook: The stock trades above its 20‑day and 50‑day moving averages but remains below the 200‑day average, indicating short‑term momentum within a longer‑term downtrend. RSI sits in the upper‑mid range and the MACD histogram is positive, suggesting bullish momentum that may be capped near the identified resistance around $20.5. Volume is increasing, yet 30‑day volatility is high at roughly 25%, and beta is very low, pointing to a stock that moves independently of the market but with pronounced price swings.
Fundamentals and valuation: Revenue is growing at ~16% with modest margins, while the PE ratio of 18.2 is well under the industry average of 24.8, and the DCF‑derived fair value implies ~22% upside. The dividend yield is attractive at over 5%, but the payout ratio approaches 97% and the company carries a high debt load (DE ratio ~68%). These factors make the stock appear fairly valued with limited margin of safety, especially given the sustainability concerns around the dividend and leverage.